EBV-TCR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-TCR-T cell therapy, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]